Skip to main content
Industry News
FDG-PET may aid prediction of cognitive decline

A study found that entorhinal hypometabolism detected by FDG-PET scans may be a strong predictor of cognitive decline in patients with preclinical Alzheimer's disease. "Adding low entorhinal FDG as inclusion criterion in preclinical AD trials would significantly increase the power of the trials, researchers wrote in Neurology.

Full Story: